Literature DB >> 23372508

The Impact of CED On Private Payers.

William Atkinson.   

Abstract

Is 'coverage with evidence development' a happy medium between 'no evidence, no coverage,' and the sky-high promise of some new biologic therapies, diagnostics, and devices? Medicare plans to find out. The application of CED raises a number of questions, the answers to which may determine whether it is a suitable model for private payers trying to answer the value equation.

Entities:  

Year:  2007        PMID: 23372508      PMCID: PMC3555183     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN: 1554-169X


  1 in total

1.  Overhauling the reimbursement system for molecular diagnostics.

Authors:  Nafees N Malik
Journal:  Nat Biotechnol       Date:  2011-05       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.